Medicines Formulary

Medicines A–Z

U

Drug name	NICE TAs	Comments
Ubidecarenone
Ulipristal 30mg		If copper IUD is not preferred/appropriate Ulipristal 30mg (EllaOne®) - (72-120hrs)
Ultibro breezhaler		Indacaterol maleate and glycopyrronium bromidfe. To be used in line with COPD guidance
Umeclidinium bromide (Incruse Ellipta®)		To be used in line with COPD guidance
Uniroid HC ointment
Uniroid HC suppositories
Upadacitinib (Rinvoq®)	TA665 - Upadacitinib for treating severe rheumatoid arthritis TA744 - Upadacitinib for treating moderate rheumatoid arthritis TA829 - Upadacitinib for treating active ankylosing spondylitis TA861 - Upadacitinib for treating active non-radiographic axial spondyloarthritis
Upadacitinib (Rinvoq®)	TA856 - Upadacitinib for treating moderately to severely active ulcerative colitis TA907 - Deucravacitinib for treating moderate to severe plaque psoriasis
Urokinase injection		Hospital use only
Ursodeoxycholic acid

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.